Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Batus, M. [1 ]
Mohajer, R. [1 ]
Pach, D. [1 ]
Basu, S. [1 ]
Fidler, M. J. [1 ]
Bonomi, P. D. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18047
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer
    Rosell, R
    Felip, E
    Massuti, B
    GonzalezLarriba, JL
    Benito, D
    LopezCabrerizo, MP
    Salamanca, O
    Camps, C
    PuertoPica, J
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 56 - 60
  • [32] Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
    Kim, Han Jo
    Kim, Kyoung Ha
    Yun, Jina
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Nam Su
    Lee, Kyu Taek
    Kim, Do-Jin
    Park, Seong-Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    CANCER RESEARCH AND TREATMENT, 2011, 43 (01): : 19 - 23
  • [33] Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer
    Natale, RB
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 2 - 6
  • [34] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [35] Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC):: A phase I/II trial.
    Sanchez, J. M.
    Mellemgaard, A.
    Perry, M.
    Zatloukal, P.
    Hamm, J.
    Belani, C. P.
    Kim, E.
    Felip, E.
    Berton, M.
    Johri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 390S - 390S
  • [36] PHASE-II TRIAL OF ORAL IDARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC)
    ARDIZZONI, A
    PRONZATO, P
    REPETTO, L
    DEPALMA, M
    CANOBBIO, L
    GULISANO, M
    FUSCO, V
    ROSSO, R
    GANZINA, F
    CANCER INVESTIGATION, 1988, 6 (04) : 409 - 411
  • [37] Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC)
    Huang, C. H.
    Williamson, S.
    Van Veldhuizen, P. J.
    Hsueh, C. T.
    Smith, H.
    Mayo, M.
    Allen, A.
    Kelly, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R
    Lee, J
    Han, J
    Tsai, C
    Boyer, M
    Mok, T
    Kim, S
    Lee, J
    Brnabic, A
    Lehnert, M
    LUNG CANCER, 2005, 49 : S92 - S92
  • [39] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC).
    Abratt, RP
    Lee, JS
    Han, JY
    Tsai, CM
    Boyer, M
    Mok, T
    Kim, SW
    Lee, JS
    Brnabic, AJM
    Lehnert, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [40] Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Saleh, M. N.
    Socinski, M. A.
    Trent, D.
    Dobbs, T.
    Zehngebot, L. M.
    Levine, M. A.
    Stella, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345